Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 18 results.
User Information
Export Records
  1. 1.   Chemical characterization of the aqueous algistatic fraction of barley straw (Hordeum vulgare) inhibiting Microcystis aeruginosa
  2. Waybright, T. J.; Terlizzi, D. E.; Ferrier, M. D.
  3. Journal of Applied Phycology. 2009 21(3): 333-340.
  1. 2.   Inhibition of transcription factor NF-kappa B signaling proteins IKK beta and p65 through specific cysteine residues by epoxyquinone A monomer: Correlation with its anti-cancer cell growth activity
  2. Liang, M. C.; Bardhan, S.; Pace, E. A.; Rosman, D.; Beutler, J. A.; Porco, J. A.; Gilmore, T. D.
  3. Biochemical Pharmacology. 2006, FEB 28; 71(5): 634-645.
  1. 3.   New arylthioindoles: Potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies
  2. De Martino, G.; Edler, M. C.; La Regina, G.; Coluccia, A.; Barbera, M. C.; Barrow, D.; Nicholson, R. I.; Chiosis, G.; Brancale, A.; Hamel, E.; Artico, M.; Silvestri, R.
  3. Journal of Medicinal Chemistry. 2006, FEB 9; 49(3): 947-954.
  1. 4.   Evaluating chemical structure similarity as an indicator of cellular growth inhibition
  2. Wallqvist, A.; Huang, R. L.; Thanki, N.; Covell, D. G.
  3. Journal of Chemical Information and Modeling. 2006, JAN-FEB; 46(1): 430-437.
  1. 5.   Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action
  2. Huan, R.; Wallqvist, A.; Thanki, N.; Covell, D.
  3. Clinical Cancer Research. 2005, DEC 15; 11(24, Part 2 Suppl. S): 9069S-9069S.
  1. 6.   Elucidation of thioredoxin as a molecular target for antitumor quinols
  2. Bradshaw, T. D.; Matthews, C. S.; Cookson, J.; Chew, E. H.; Shah, M.; Bailey, K.; Monks, A.; Harris, E.; Westwell, A. D.; Wells, G.; Laughton, C. A.; Stevens, M. F. G.
  3. Cancer Research. 2005, MAY 1; 65(9): 3911-3919.
  1. 7.   Role of glutathione and nucleotide excision repair in modulation of cisplatin activity with O-6-benzylguanine
  2. Fishel, M. L.; Ganicsik, M. P.; Delaney, S. M.; Zuhowski, E. G.; Maher, V. M.; Karrison, T.; Moschel, R. C.; Egorin, M. J.; Dolan, M. E.
  3. Cancer Chemotherapy and Pharmacology. 2005, APR; 55(4): 333-342.
  1. 8.   Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action
  2. Huang, R.; Wallqvist, A.; Thanki, N.; Covell, D. G.
  3. Pharmacogenomics Journal. 2005 5(6): 381-399.
  1. 9.   Secondary metabolites of Phlomis viscosa and their biological activities
  2. Calis, I.; Kirmizibekmez, H.; Beutler, J. A.; Donmez, A. A.; Yalcin, F. N.; Kilic, E.; Ozalp, M.; Ruedi, P.; Tasdemir, D.
  3. Turkish Journal of Chemistry. 2005 29(1): 71-81.
  1. 10.   Caspase-mediated apoptosis and caspase-independent cell death induced by irofulven in prostate cancer cells
  2. Liang, H. Y.; Salinas, R. A.; Leal, B. Z.; Kosakowska-Cholody, T.; Michejda, C. J.; Waters, S. J.; Herman, T. S.; Woynarowski, J. M.; Woynarowska, B. A.
  3. Molecular Cancer Therapeutics. 2004, NOV; 3(11): 1385-1396.
  1. 11.   Schedule-dependent inhibition of hypoxia-inducible factor-1 alpha protein accumulation, angiogenesis, and tumor growth by topotecan in U251-HRE glioblastoma xenografts
  2. Rapisarda, A.; Zalek, J.; Hollingshead, M.; Braunschweig, T.; Uranchimeg, B.; Bonomi, C. A.; Borgel, S. D.; Carter, J. P.; Hewitt, S. M.; Shoemaker, R. H.; Melillo, G.
  3. Cancer Research. 2004, OCT 1; 64(19): 6845-6848.
  1. 12.   Preferential response of cancer cells to zebularine
  2. Cheng, J. C.; Yoo, C. B.; Weisenberger, D. J.; Chuang, J.; Wozniak, C.; Liang, G. N.; Marquez, V. E.; Greer, S.; Orntoft, T. F.; Thykjaer, T.; Jones, P. A.
  3. Cancer Cell. 2004, AUG; 6(2): 151-158.
  1. 13.   Transcriptional coregulator SNURF (RNF4) possesses ubiquitin E3 ligase activity
  2. Hakli, M.; Lorick, K. L.; Weissman, A. M.; Janne, O. A.; Palvimo, J. J.
  3. Febs Letters. 2004 560(1-3): 56-62.
  1. 14.   Sensitivity of renal cell carcinoma to aminoflavone: Role of CYP1A1
  2. Loaiza-Perez, A. I.; Kenney, S.; Boswell, J.; Hollingshead, M.; Hose, C.; Linehan, W. M.; Worrell, R.; Rubinstein, L.; Sausville, A.; Vistica, D. T.
  3. Journal of Urology. 2004 171(4): 1688-1697.
  1. 15.   Tuberous sclerosis complex 2 gene product interacts with human SMAD proteins - A molecular link of two tumor suppressor pathways
  2. Birchenall-Roberts, M. C.; Fu, T.; Bang, O. S.; Dambach, M.; Resau, J. H.; Sadowski, C. L.; Bertolette, D. C.; Lee, H. J.; Kim, S. J.; Ruscetti, F. W.
  3. Journal of Biological Chemistry. 2004 279(24): 25605-25613.
  1. 16.   Responsiveness to transforming growth factor-beta (TGF-beta)- mediated growth inhibition is a function of membrane-bound TGF- beta type II receptor in human breast cancer cells
  2. Lynch, M. A.; Petrel, T. A.; Song, H.; Knobloch, T. J.; Casto, B. C.; Ramljak, D.; Anderson, L. M.; DeGroff, V.; Stoner, G. D.; Brueggemeier, R. W.; Weghorst, C. M.
  3. Gene Expression. 2001 9(4-5): 157-171.
  1. 17.   Overexpression of candidate tumor suppressor gene FUS1 isolated from the 3p21.3 homozygous deletion region leads to G1 arrest and growth inhibition of lung cancer cells
  2. Kondo, M.; Ji, L.; Kamibayashi, C.; Tomizawa, Y.; Randle, D.; Sekido, Y.; Yokota, J.; Kashuba, V.; Zabarovsky, E.; Kuzmin, I.; Lerman, M.; Roth, J.; Minna, J. D.
  3. Oncogene. 2001 20(43): 6258-6262.
  1. 18.   Mutational Analysis of Human Prothymosin Alpha Reveals a Bipartite Nuclear Localization Signal
  2. Rubtsov, Y. P.; Zolotukhin, A. S.; Vorobjev, I. A.; Chichkova, N. V.; Pavlov, N. A.; Karger, E. M.; Evstafieva, A. G.; Felber, B. K.; Vartapetian, A. B.
  3. Febs Letters. 1997 413(1): 135-141.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel